Hydrogenosome
Hydrogenosome is an organelle found in some eukaryotic microorganisms. The hydrogenosome is a double-membrane-bound organelle that produces molecular hydrogen as a byproduct of energy extraction from sugars. It was first discovered in the anaerobic protozoan Trichomonas vaginalis by Miklós Müller in 1973.
Structure and Function[edit]
The hydrogenosome is similar in size to mitochondria, but unlike mitochondria, it lacks cristae and mitochondrial DNA. The hydrogenosome's primary function is to generate ATP through the process of fermentation. This process involves the decarboxylation of pyruvate, the end product of glycolysis, to form Acetyl-CoA, which is then converted to acetate, releasing energy in the form of ATP.
Evolution[edit]
The hydrogenosome is believed to have evolved from the same endosymbiotic event that gave rise to mitochondria. This theory, known as the endosymbiotic theory, suggests that an ancestral eukaryotic cell engulfed an aerobic prokaryote, which then became an endosymbiont, eventually evolving into the mitochondrion. In the case of the hydrogenosome, it is thought that the organelle evolved from a mitochondrion in an ancestor that adapted to an anaerobic environment.
Distribution[edit]
Hydrogenosomes have been found in a variety of anaerobic eukaryotic microorganisms, including Trichomonas vaginalis, Giardia lamblia, and Neocallimastix spp.. These organisms inhabit environments that are low in oxygen, such as the human gut or vagina.
Significance[edit]
The study of hydrogenosomes has provided insights into the evolution of eukaryotic cells and their organelles. Furthermore, because hydrogenosomes are found in several pathogenic organisms, they are of interest in the development of new treatments for diseases such as trichomoniasis and giardiasis.
Hydrogenosome[edit]
-
Hydrogenosome diagram
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
